Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity
2019 · Cell Metabolism · 109 citations
https://doi.org/10.1016/j.cmet.2019.01.011
D
David A. Rizzieri
Novant Health(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
587
Papers
17.8K
Citations
64
h-index
242
i10-index
David A. Rizzieri is an academic researcher from Novant Health. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Acute Lymphoblastic Leukemia research. The author has an h-index of 64, co-authored 499 publications.
ORCID: 0000-0001-9886-5771Papers by this author
worksAn open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
2016 · Leukemia & lymphoma/Leukemia and lymphoma · 74 citations
https://doi.org/10.3109/10428194.2015.1122781
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
2021 · Blood Advances · 74 citations
https://doi.org/10.1182/bloodadvances.2021004916
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
2015 · Biology of Blood and Marrow Transplantation · 53 citations
https://doi.org/10.1016/j.bbmt.2015.05.010
Fludarabine-Based Nonmyeloablative Stem Cell Transplantation for Sickle Cell Disease with and without Renal Failure: Clinical Outcome and Pharmacokinetics
2007 · Biology of Blood and Marrow Transplantation · 46 citations
https://doi.org/10.1016/j.bbmt.2007.08.050
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
2021 · Leukemia · 39 citations
https://doi.org/10.1038/s41375-021-01213-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat